Related Experiment Video
Updated: May 10, 2026

17:12
Profiling of Methyltransferases and Other S-adenosyl-L-homocysteine-binding Proteins by Capture Compound Mass Spectrometry CCMS
Published on: December 20, 2010
15.7K
MutationAssessor in cBioPortal
Yang Su1, Xiang Li2, Boris Reva3
1Department of Systems Biology, Harvard Medical School, Boston, MA, USA.
Biorxiv : the Preprint Server for Biology
|August 20, 2025
Summary
MutationAssessor (MA) version 4 refines functional impact scoring for cancer mutations. It enhances analysis of protein conservation and variant pathogenicity, aiding cancer genomics research.
Area of Science:
- Genomics
- Bioinformatics
- Computational Biology
Background:
- Somatic and germline mutations in cancer require functional impact assessment.
- MutationAssessor (MA) provides an evolution-based functional impact score (FIS) for mutations.
- FIS scores leverage conservation patterns in protein families and subfamilies.
Purpose of the Study:
- To introduce version 4 (r4) of MutationAssessor with significant improvements.
- To refine the analysis of protein conservation patterns and sequence alignments.
- To validate predicted functional impacts against curated variant databases and germline frequencies.
Main Methods:
- Refined combinatorial entropy analysis of conservation patterns.
- Recalculated full-length protein multiple sequence alignments using extensive sequence data.
- Comparison of predicted functional impact with ClinVar classifications.
- Analysis of variant frequency in germline genome sequences.
- Exploration of switch-of-function mutational effects.
Main Results:
- Enhanced accuracy in predicting the functional impact of cancer mutations.
- Validation of FIS scores against known pathogenic and benign variants.
- Observed inverse correlation between high functional impact and germline variant frequency.
- Availability of functional impact data for ~4 million somatic mutations in cBioPortal.
Conclusions:
- MutationAssessor r4 offers a robust tool for evaluating the functional consequences of cancer mutations.
- The updated FIS provides valuable insights into mutation pathogenicity and evolutionary conservation.
- The integration of MA data into cBioPortal facilitates cancer genomics research and clinical interpretation.

